F Caballero-Fonseca
Overview
Explore the profile of F Caballero-Fonseca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F, Gonzalez-Aveledo L
Eur Ann Allergy Clin Immunol
. 2018 Jan;
50(1):5-9.
PMID: 29350016
Currently there are no biomarkers useful to predict the future evolution and the therapeutic response in patients with chronic spontaneous urticaria (CSU). To review the available information on biomarkers that...
2.
Sanchez-Borges M, Gonzalez-Aveledo L, Capriles-Hulett A, Caballero-Fonseca F
Allergol Immunopathol (Madr)
. 2017 Dec;
46(3):276-280.
PMID: 29279260
Scabies is observed with relatively high frequency in Allergy and Dermatology clinics in developing countries where poor sanitary conditions are prevalent and increasingly in some areas of the world with...
3.
Sanchez-Borges M, Capriles-Hulet A, Caballero-Fonseca F, Gonzalez-Aveledo L
Eur Ann Allergy Clin Immunol
. 2017 Jul;
49(4):148-153.
PMID: 28752717
Monoclonal anti-IgE antibodies (omalizumab) are able to induce clinically significant benefits in patients with severe chronic spontaneous urticaria (CS). Those results led clinicians and investigators to reconsider a possible pathogenic...
4.
Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, Gonzalez-Aveledo L, Maurer M
J Eur Acad Dermatol Venereol
. 2017 Mar;
31(6):964-971.
PMID: 28299827
Biomarkers useful for the evaluation and management of patients with chronic spontaneous urticaria (CSU) are not currently available. A review of various clinical and laboratory markers that have been studied...
5.
Bousquet J, Farrell J, Crooks G, Hellings P, Bel E, Bewick M, et al.
Clin Transl Allergy
. 2017 Feb;
7:5.
PMID: 28239450
[This corrects the article DOI: 10.1186/s13601-016-0116-9.].
6.
Bousquet J, Hellings P, Agache I, Bedbrook A, Bachert C, Bergmann K, et al.
Clin Transl Allergy
. 2017 Jan;
6:47.
PMID: 28050247
The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis...
7.
Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A
Allergol Immunopathol (Madr)
. 2016 Nov;
45(6):573-578.
PMID: 27865540
Hypersensitivity reactions to aspirin and other NSAIDs occur in individuals genetically predisposed and exhibit different clinical manifestations, especially respiratory, cutaneous, and generalised. Five different phenotypes define distinct clinical pictures: aspirin-exacerbated...
8.
Bousquet J, Farrell J, Crooks G, Hellings P, Bel E, Bewick M, et al.
Clin Transl Allergy
. 2016 Aug;
6:29.
PMID: 27478588
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated...
9.
Bousquet J, Schunemann H, Fonseca J, Samolinski B, Bachert C, Canonica G, et al.
Allergy
. 2015 Jul;
70(11):1372-92.
PMID: 26148220
Several unmet needs have been identified in allergic rhinitis: identification of the time of onset of the pollen season, optimal control of rhinitis and comorbidities, patient stratification, multidisciplinary team for...
10.
Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A
Eur Ann Allergy Clin Immunol
. 2014 Nov;
46(6):210-5.
PMID: 25398164
Chronic urticaria (CU) is one of the most puzzling clinical entities confronted by the medical profession. It is a common motive for consultation, and in a sizable proportion of patients...